First Time Loading...

Sangamo Therapeutics Inc
NASDAQ:SGMO

Watchlist Manager
Sangamo Therapeutics Inc Logo
Sangamo Therapeutics Inc
NASDAQ:SGMO
Watchlist
Price: 0.5614 USD 7.26% Market Closed
Updated: May 12, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

165.3m
-25%
Assets
Growth Rates:
1 Year
-71%
3 Years
-82%
5 Years
-72%
7 Years
+5%
10 Years
+17%
82.4m
-3%
Liabilities
Growth Rates:
1 Year
-69%
3 Years
-81%
5 Years
-63%
7 Years
+280%
10 Years
+332%
82.9m
-39%
Equity
Growth Rates:
1 Year
-72%
3 Years
-83%
5 Years
-77%
7 Years
-39%
10 Years
-32%

Balance Sheet Decomposition
Sangamo Therapeutics Inc

165.3m
Assets
82.4m
Liabilities
165.3m
Assets
82.4m
Liabilities
Current Assets 94.3m
Cash & Short-Term Investments 81m
Receivables 1.3m
Other Current Assets 12m
Non-Current Assets 71m
PP&E 52.9m
Other Non-Current Assets 18.1m
Current Liabilities 47.7m
Accounts Payable 15.3m
Accrued Liabilities 32.5m
Non-Current Liabilities 34.7m
Other Non-Current Liabilities 34.7m

Balance Sheet
Sangamo Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
6
70
22
50
140
80
131
179
100
45
Cash Equivalents
6
70
22
50
140
80
131
179
100
45
Short-Term Investments
173
140
121
194
260
282
510
198
177
36
Total Receivables
11
3
5
4
5
38
6
6
5
1
Accounts Receivables
10
3
5
3
5
37
5
6
4
1
Other Receivables
0
0
0
0
0
1
1
0
1
0
Other Current Assets
1
1
2
2
5
5
12
16
18
12
Total Current Assets
191
213
150
248
411
406
660
399
300
94
PP&E Net
2
3
7
31
79
107
112
125
126
53
PP&E Gross
2
3
7
31
79
107
112
125
126
53
Accumulated Depreciation
4
5
6
7
9
12
17
25
37
51
Intangible Assets
2
0
0
0
55
53
58
54
51
0
Goodwill
2
2
2
2
40
39
43
40
38
0
Long-Term Investments
47
0
0
1
0
22
51
88
30
0
Other Long-Term Assets
0
0
0
5
6
11
15
17
19
18
Other Assets
2
2
2
2
40
39
43
40
38
0
Total Assets
243
N/A
217
-11%
158
-27%
287
+82%
590
+106%
638
+8%
939
+47%
722
-23%
563
-22%
165
-71%
Liabilities
Accounts Payable
6
4
3
0
3
7
6
10
22
15
Accrued Liabilities
6
7
6
15
22
22
49
31
34
21
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
10
10
5
30
53
41
101
88
55
12
Total Current Liabilities
21
20
13
45
79
70
144
128
112
48
Long-Term Debt
0
0
4
25
0
0
0
0
0
0
Deferred Income Tax
1
0
0
0
7
7
7
7
6
0
Minority Interest
0
0
0
0
1
0
1
0
0
0
Other Liabilities
15
5
5
29
138
128
291
212
150
35
Total Liabilities
37
N/A
25
-32%
22
-13%
99
+355%
224
+127%
205
-8%
440
+115%
347
-21%
268
-23%
82
-69%
Equity
Common Stock
1
1
1
1
1
1
1
2
2
2
Retained Earnings
329
369
441
496
563
657
778
956
1 149
1 406
Additional Paid In Capital
535
561
576
683
930
1 091
1 269
1 334
1 450
1 492
Other Equity
0
0
0
0
1
2
5
4
8
5
Total Equity
207
N/A
192
-7%
136
-29%
188
+38%
367
+95%
433
+18%
498
+15%
375
-25%
295
-21%
83
-72%
Total Liabilities & Equity
243
N/A
217
-11%
158
-27%
287
+82%
590
+106%
638
+8%
939
+47%
722
-23%
563
-22%
165
-71%
Shares Outstanding
Common Shares Outstanding
69
70
71
86
102
116
142
146
167
178

See Also

Summary
SGMO intrinsic value, competitors valuation, and company profile.
DCF Valuation
SGMO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SGMO stock valuation using valuation multiples.
Wall Street Estimates
SGMO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SGMO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.